Toggle navigation
Home
Search
Services
Blog
Contact
About
HIV GP120 Glycoconjugate Vaccines
Paoletti, Lawrence C.
Brigham and Women's Hospital, Boston, MA, United States
Search 12 grants from Lawrence Paoletti
Search grants from Brigham and Women's Hospital
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Analysis of Historical Influenza Viruses
Nonparametric Bayes Methods for Biomedical Studies
Nanog-positive cancer stem cells in and liver oncogenesis by alcohol and HCV
Consultations on Applications of Multi Photon Microscopy
Phase II/III Clinical Trials of Anticancer Agents
Recently added grants:
Synthetic lethality screens in a nutrient sensitized Toxoplasma strain to identify novel proteins that mediate nutrient acquisition in chronic Toxoplasma infection.
Defining Siglec-6 and Siglec-8 function on effector cells of allergic diseases
Role of mTOR signaling in endothelial responses to Rickettsia rickettsii infection.
Siglec-targeted nanoparticles for treating mast cell mediated allergic disease
Post-transcriptional Gene Regulation by EBV SM Protein.
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI045391-02
Application #
6349912
Study Section
Special Emphasis Panel (ZRG1-VACC (03))
Program Officer
Bradac, James A
Project Start
2000-02-15
Project End
2004-01-31
Budget Start
2001-02-01
Budget End
2004-01-31
Support Year
2
Fiscal Year
2001
Total Cost
$239,547
Indirect Cost
Institution
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 2001
R21 AI
HIV GP120 Glycoconjugate Vaccines
Paoletti, Lawrence C. / Brigham and Women's Hospital
$239,547
NIH 2000
R21 AI
HIV GP120 Glycoconjugate Vaccines
Paoletti, Lawrence C. / Brigham and Women's Hospital
$246,086
Publications
Paoletti, Lawrence C; Kennedy, Ronald C
(2002)
Neutralizing antibody induced in mice by novel glycoconjugates of human immunodeficiency virus type 1 gp120 and env2-3.
J Infect Dis 186:1597-602
Comments
Be the first to comment on Lawrence Paoletti's grant